These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1907031)

  • 1. Modulation of splanchnic vascular sensitivity to angiotensin II.
    Wu YP; Li SS; Campbell KA; Sitzmann JV
    Surgery; 1991 Aug; 110(2):162-8. PubMed ID: 1907031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.
    Sitzmann JV; Li SS; Lin PW
    J Surg Res; 1989 Sep; 47(3):208-11. PubMed ID: 2504995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased mesenteric vascular response to angiotensin II in portal hypertension.
    Sitzmann JV; Li SS; Wu YP; Groszmann R; Bulkley GB
    J Surg Res; 1990 Apr; 48(4):341-4. PubMed ID: 2338820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II increases portosystemic collateral resistance in portal hypertension.
    Campbell KA; Wu YP; Sitzmann JV
    J Surg Res; 1991 Sep; 51(3):181-5. PubMed ID: 1881131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
    Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
    World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.
    Sitzmann JV; Bulkley GB; Mitchell MC; Campbell K
    Ann Surg; 1989 Mar; 209(3):322-7. PubMed ID: 2493776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of portosystemic shunting by prostacyclin in portal hypertension.
    Campbell KA; Wu YP; Sitzmann JV
    Curr Surg; 1990; 47(1):17-9. PubMed ID: 2107062
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced nitric oxide synthase activity in portal hypertensive rabbits.
    Cahill PA; Foster C; Redmond EM; Gingalewski C; Wu Y; Sitzmann JV
    Hepatology; 1995 Aug; 22(2):598-606. PubMed ID: 7543437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of angiotensin-II receptors in portal hypertensive rabbits.
    Sitzmann JV; Wu Y; Aguilera G; Cahill PA; Burns RC
    Hepatology; 1995 Aug; 22(2):559-64. PubMed ID: 7635425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and portal prostacyclin and thromboxane response to hemorrhage in portal hypertension.
    Wu Y; Burns C; Campbell KA; Sitzmann JV
    Shock; 1994 Jul; 2(1):68-71. PubMed ID: 7735986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo.
    Tofovic SP; Jackson EK
    J Pharmacol Exp Ther; 1996 Jan; 276(1):13-20. PubMed ID: 8558421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
    Heller J; Trebicka J; Shiozawa T; Schepke M; Neef M; Hennenberg M; Sauerbruch T
    Liver Int; 2005 Jun; 25(3):657-66. PubMed ID: 15910503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.